|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.17 INR | -2.13% |
|
+12.80% | -32.50% |
| Market Cap | 976M 10.34M 9.02M 8.35M 7.82M 14.66M 14.75M 99.07M 38.4M 480M 38.82M 37.99M 1.67B | P/E 2024 |
-14.8x | P/E 2025 | -22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.34B 14.25M 12.42M 11.5M 10.77M 20.2M 20.32M 136M 52.89M 662M 53.47M 52.33M 2.3B | EV / Sales 2024 |
12,382,225x | EV / Sales 2025 | 14,298,457x |
| Free-Float |
25.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.13% | ||
| 1 week | +12.80% | ||
| Current month | +6.03% | ||
| 1 month | +9.35% | ||
| 3 months | -3.16% | ||
| 6 months | -35.27% | ||
| Current year | -32.50% |
| 1 week | 27.67 | 34.2 | |
| 1 month | 25.6 | 34.2 | |
| Current year | 25.6 | 50.9 | |
| 1 year | 25.6 | 70 | |
| 3 years | 25.6 | 87.46 | |
| 5 years | 10.17 | 87.46 | |
| 10 years | 2.15 | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 13/10/2022 | |
| Chief Tech/Sci/R&D Officer | - | 07/08/2025 | |
| Compliance Officer | - | 14/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Mini Manikantan
BRD | Director/Board Member | - | 09/07/2022 |
| Director/Board Member | - | - | |
| Chairman | 74 | 05/12/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.13% | +12.80% | -43.75% | +7.23% | 12.3M | ||
| +32.62% | -5.37% | +39.94% | +145.38% | 980B | ||
| -3.20% | -4.17% | +51.52% | +39.07% | 550B | ||
| -2.14% | -3.68% | +16.71% | +56.15% | 382B | ||
| -1.75% | +0.25% | +25.86% | +16.53% | 317B | ||
| +0.61% | -1.69% | +25.42% | +13.64% | 270B | ||
| +0.22% | -3.10% | +24.25% | +30.21% | 269B | ||
| +4.59% | +1.98% | -40.02% | -45.89% | 191B | ||
| -1.90% | -4.65% | +16.56% | +47.00% | 182B | ||
| -1.35% | -1.68% | +14.59% | +56.94% | 154B | ||
| Average | -0.66% | -0.89% | +13.11% | +36.63% | 329.41B | |
| Weighted average by Cap. | -0.97% | -3.38% | +28.25% | +64.05% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 151.12 1.6 1.4 1.29 1.21 2.27 2.28 15.34 5.95 74.38 6.01 5.88 258.28 | 195.14 2.07 1.8 1.67 1.56 2.93 2.95 19.81 7.68 96.05 7.76 7.6 333.51 |
| Net income | -79.68M -844K -736K -682K -638K -1.2M -1.2M -8.09M -3.14M -39.22M -3.17M -3.1M -136M | -108M -1.14M -996K -922K -863K -1.62M -1.63M -10.94M -4.24M -53.04M -4.29M -4.2M -184M |
| Net Debt | 37.29M 395K 345K 319K 299K 560K 564K 3.79M 1.47M 18.35M 1.48M 1.45M 63.73M | 368M 3.9M 3.4M 3.15M 2.95M 5.53M 5.57M 37.39M 14.49M 181M 14.65M 14.34M 629M |
Employees
28
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/06/26 | 32.17 ₹ | -2.13% | 13,823 |
| 18/06/26 | 32.87 ₹ | +1.83% | 10,926 |
| 17/06/26 | 32.28 ₹ | +12.32% | 25,178 |
| 16/06/26 | 28.74 ₹ | -2.31% | 8,953 |
| 15/06/26 | 29.42 ₹ | +1.59% | 11,210 |
- Stock Market
- Stocks
- PHARMAID Stock
Select your edition
All financial news and data tailored to specific country editions
















